A Population-Based Study of the Incidence and Complication Rates of Herpes Zoster Before Zoster Vaccine Introduction

作者: Barbara P. Yawn , Patricia Saddier , Peter C. Wollan , Jennifer L. St. Sauver , Marge J. Kurland

DOI: 10.4065/82.11.1341

关键词: Varicella zoster virusHerpes Zoster VaccineZoster vaccinePopulationIncidence (epidemiology)MedicineRochester Epidemiology ProjectSurgeryEpidemiologyPostherpetic neuralgiaPediatrics

摘要: Objective To establish accurate, up-to-date, baseline epidemiological data for herpes zoster (HZ) before the introduction of recently licensed HZ vaccine. Methods Using from January 1, 1996, to October 15, 2005, we conducted a population-based study adult residents (Greater than or equal 22 years) Olmsted County, MN, determine (by medical record review) incidence and rate HZ-related complications. Incidence rates were determined by age sex adjusted US population. Results A total 1669 with confirmed diagnosis identified between December 31, 2001. Most (92%) these patients immunocompetent 60% women. When population, was 3.6 per 1000 person-years (95% confidence interval, 3.4-3.7), temporal increase 3.2 4.1 1996 The HZ-associated complications increased age, 68% cases occurring in those aged 50 years older. Postherpetic neuralgia occurred 18% 33% 79 Overall, 10% all experienced 1 more nonpain Conclusions Our suggest that primarily affects adults older years; 4 experiences some type complication.

参考文章(50)
John W. Gnann, Richard J. Whitley, Herpes Zoster New England Journal of Medicine. ,vol. 347, pp. 340- 346 ,(2002) , 10.1056/NEJMCP013211
R Edgar Hope-Simpson, THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS. Journal of the Royal Society of Medicine. ,vol. 58, pp. 9- 20 ,(1965) , 10.1177/003591576505800106
Antoine Flahault, Olivier Chosidow, A. Dupuy, S. Czernichow, Zona: enquête d'incidence chez les médecins généralistes du réseau « Sentinelles » Annales De Dermatologie Et De Venereologie. ,vol. 128, pp. 497- 501 ,(2001)
John Hornberger, Katherine Robertus, Cost-Effectiveness of a Vaccine To Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults Annals of Internal Medicine. ,vol. 145, pp. 317- 325 ,(2006) , 10.7326/0003-4819-145-5-200609050-00004
Leonard T. Kurland, Craig A. Molgaard, The patient record in epidemiology. Scientific American. ,vol. 245, pp. 54- 63 ,(1981) , 10.1038/SCIENTIFICAMERICAN1081-54
JOSE M. de MORAGAS, The Outcome of Patients with Herpes Zoster Archives of Dermatology. ,vol. 75, pp. 193- 196 ,(1957) , 10.1001/ARCHDERM.1957.01550140037006
R.H. Dworkin, A.E. Corbin, J.P. Young, U. Sharma, L. LaMoreaux, H. Bockbrader, E.A. Garofalo, R.M. Poole, Pregabalin for the treatment of postherpetic neuralgia A randomized, placebo-controlled trial Neurology. ,vol. 60, pp. 1274- 1283 ,(2003) , 10.1212/01.WNL.0000055433.55136.55
Umberto di Luzio Paparatti, Fabio Arpinelli, Giovanni Visonà, Herpes zoster and its complications in Italy: an observational survey. Journal of Infection. ,vol. 38, pp. 116- 119 ,(1999) , 10.1016/S0163-4453(99)90079-8
M. W. RAGOZZINO, L. J. MELTON, L. T. KURLAND, C. P. CHU, H. O. PERRY, Population-based study of herpes zoster and its sequelae. Medicine. ,vol. 61, pp. 310- 316 ,(1982) , 10.1097/00005792-198209000-00003